It was reported that DNA damage increases upon combining ATR suppression with MYC overexpression 23 and Chk1 inhibitors were highly effective in killing MYC-driven lymphomas 24, suggesting synthetic lethality as a treatment strategy for MYC-overexpressing tumors. The gene discussed is CHEK1; the disease is lymphoma.